You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Research Articles
Popular Research Articles
Highly Recommended Research Articles
Send a link to this page to your friends and colleagues.
Zyprexa (olanzapine), which belongs to a family of drugs known as atypical anti-psychotics, could be a factor in the development of diabetes.
The drug, manufactured by Eli Lilly, is used to treat schizophrenia, paranoia, and manic-depressive disorders, according to a news release from Duke University.
In a retrospective study, researchers from Duke University and the U.S. Food and Drug Administration identified 237 cases of diabetes between January 1994 and May 15 2001, in people who had taken Zyprexa—including 188 newly diagnosed cases. Of the total, 80 people developed ketosis, 41 had glucose levels of 1,000 mg/dl or higher and there were 15 deaths. Nearly three-quarters of the cases began within six months of starting treatment with Zyprexa.
While it is uncertain that Zyprexa causes diabetes, researchers say that the number of reports, their relationship to the initiation of Zyprexa and improved blood-glucose control when the drug is stopped suggest that it is responsible for either precipitating or unmasking diabetes in people who are susceptible.
—Pharmacotherapy, July 2002
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.